Gene · 3140
Papers1,845
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,845
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage. | J Exp Med | 2023 | 36939517 | PubTator, text mining | PubMed |
| HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9. | Front Cell Dev Biol | 2023 | 36936678 | PubTator, text mining | PubMed |
| Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population. | Medicine (Baltimore) | 2023 | 36930114 | PubTator, text mining | PubMed |
| MAIT cells and the microbiome. | Front Immunol | 2023 | 36911683 | PubTator, text mining | PubMed |
| Relevant mechanisms of MAIT cells involved in the pathogenesis of periodontitis. | Front Cell Infect Microbiol | 2023 | 36896188 | PubTator, text mining | PubMed |
| Pathogenesis, epidemiology and control of Group A Streptococcus infection. | Nat Rev Microbiol | 2023 | 36894668 | PubTator, text mining | PubMed |
| Translatome analyses by bio-orthogonal non-canonical amino acid labeling reveal that MR1-activated MAIT cells induce an M1 phenotype and antiviral programming in antigen-presenting monocytes. | Front Immunol | 2023 | 36875139 | PubTator, text mining | PubMed |
| Recovering from the Unprecedented Backsliding in Immunization Coverage: Learnings from Country Programming in Five Countries through the Past Two Years of COVID-19 Pandemic Disruptions. | Vaccines (Basel) | 2023 | 36851253 | PubTator, text mining | PubMed |
| Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation. | Front Immunol | 2023 | 36845106 | PubTator, text mining | PubMed |
| Graft-versus-Host Disease Modulation by Innate T Cells. | Int J Mol Sci | 2023 | 36835495 | PubTator, text mining | PubMed |
| A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin. | Biology (Basel) | 2023 | 36829532 | PubTator, text mining | PubMed |
| Innate immune responses in pneumonia. | Pneumonia (Nathan) | 2023 | 36829255 | PubTator, text mining | PubMed |
| Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes. | Sci Adv | 2023 | 36827371 | PubTator, text mining | PubMed |
| Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells. | Front Immunol | 2023 | 36793723 | PubTator, text mining | PubMed |
| Targeted multi-omic analysis of human skin tissue identifies alterations of conventional and unconventional T cells associated with burn injury. | Elife | 2023 | 36790939 | PubTator, text mining | PubMed |
| Anti-inflammatory Action of BT75, a Novel RARα Agonist, in Cultured Microglia and in an Experimental Mouse Model of Alzheimer's Disease. | Neurochem Res | 2023 | 36781685 | PubTator, text mining | PubMed |
| The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules. | J Biol Chem | 2023 | 36758805 | PubTator, text mining | PubMed |
| An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines. | J Pharm Sci | 2023 | 36736775 | PubTator, text mining | PubMed |
| Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease. | Clin Mol Hepatol | 2023 | 36727210 | PubTator, text mining | PubMed |
| Next-generation antigen-presenting cell immune therapeutics for gliomas. | J Clin Invest | 2023 | 36719372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3140/papers?page=16